← All trials
NCT07273006
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Sep 1, 2026
- Primary completion
- Nov 1, 2028
- Completion date
- Aug 31, 2029
- First posted
- Dec 9, 2025
- Last posted
- Dec 9, 2025
- Enrollment
- 82
- Arms / groups
- 4 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Universidad Complutense de MadridLead sponsor
- Jagiellonian UniversityCollaborator
- Medical University of WarsawCollaborator
- Universidad Complutense de MadridOfficial
- Universidad Complutense de MadridSponsor investigator
- Universidad Francisco de VitoriaCollaborator
Drugs studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.